Graham Capital Management L.P. Decreases Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Graham Capital Management L.P. lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 16.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 127,324 shares of the pharmacy operator's stock after selling 24,983 shares during the quarter. Graham Capital Management L.P.'s holdings in Walgreens Boots Alliance were worth $1,188,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of Walgreens Boots Alliance by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock valued at $805,506,000 after buying an additional 2,279,495 shares in the last quarter. Invesco Ltd. raised its position in Walgreens Boots Alliance by 8.8% in the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock worth $303,902,000 after purchasing an additional 2,631,332 shares during the period. Geode Capital Management LLC raised its position in Walgreens Boots Alliance by 5.2% in the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock worth $194,082,000 after purchasing an additional 1,020,587 shares during the period. Charles Schwab Investment Management Inc. raised its position in Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock worth $122,737,000 after purchasing an additional 2,185,950 shares during the period. Finally, Northern Trust Corp raised its position in Walgreens Boots Alliance by 18.8% in the 4th quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator's stock worth $83,007,000 after purchasing an additional 1,407,973 shares during the period. Hedge funds and other institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Up 1.0%

NASDAQ:WBA traded up $0.11 during mid-day trading on Friday, hitting $11.29. 5,903,657 shares of the company's stock were exchanged, compared to its average volume of 21,116,798. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $18.17. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The business has a fifty day moving average price of $11.02 and a 200 day moving average price of $10.36. The company has a market cap of $9.76 billion, a PE ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.77.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping the consensus estimate of $0.53 by $0.10. The business had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance's quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.20 earnings per share. Equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Insider Transactions at Walgreens Boots Alliance

In other news, Chairman Stefano Pessina bought 832,258 shares of the company's stock in a transaction dated Sunday, April 27th. The shares were purchased at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the purchase, the chairman now owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This represents a 0.57% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 17.50% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on WBA shares. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their target price for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, May 13th. They issued a "hold" rating on the stock. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Finally, Truist Financial decreased their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance presently has an average rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.